Literature DB >> 20938703

Nasopharyngeal bacterial colonization during the first wheezing episode is associated with longer duration of hospitalization and higher risk of relapse in young children.

T Jartti1, S Kuneinen, P Lehtinen, V Peltola, T Vuorinen, M Leinonen, O Ruuskanen.   

Abstract

The purpose of this study was to examine the association between bacterial colonization/infection and respiratory outcomes in children younger than 3 years old who were hospitalized for their first wheezing episode. This was an observational study. The primary outcome was hospitalization time and the secondary outcomes included relapses within 2 months and time to recurrent wheezing (i.e. three physician confirmed wheezing episodes) within 12 months. Bacterial antibody assays for Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Mycoplasma pneumoniae and Chlamydia pneumoniae were studied as well as nasopharyngeal bacterial culture for the three former and urine pneumococcal antigen. Nasopharyngeal bacterial culture was positive in 31/52 (60%) children, serologic evidence of bacterial infection was found in 17/96 (18%) children, urine pneumococcal antigen was positive in 24/101 (24%), and any bacterial detection method was positive in 53/106 (50%) children. The children with positive nasopharyngeal bacterial culture had longer duration of hospitalization (hazard ratio 2.4) and more often relapsed within two months than those with negative culture (odds ratio 7.3). In this study, half of the first time wheezing children had bacterial colonization or symptomatic or asymptomatic bacterial infection. The bacterial colonization (i.e. positive nasopharyngeal bacterial culture) was associated with longer duration of hospitalization and higher risk of recurrent wheezing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938703     DOI: 10.1007/s10096-010-1075-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  41 in total

1.  Antibiotic-resistant pneumococci carried by young children do not appear to disseminate to adult members of a closed community.

Authors:  A Borer; H Meirson; N Peled; N Porat; R Dagan; D Fraser; J Gilad; N Zehavi; P Yagupsky
Journal:  Clin Infect Dis       Date:  2001-07-11       Impact factor: 9.079

Review 2.  Dynamics of nasopharyngeal colonization by potential respiratory pathogens.

Authors:  J A García-Rodríguez; M J Fresnadillo Martínez
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 3.  Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies.

Authors:  Patrick G Holt; John W Upham; Peter D Sly
Journal:  J Allergy Clin Immunol       Date:  2005-07       Impact factor: 10.793

4.  Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus.

Authors:  Tuomas Jartti; Pasi Lehtinen; Timo Vanto; Jaakko Hartiala; Tytti Vuorinen; Mika J Mäkelä; Olli Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2006-06       Impact factor: 2.129

5.  Identification of human metapneumovirus and Chlamydophila pneumoniae in children with asthma and wheeze in Singapore.

Authors:  B H Ong; Q Gao; M C Phoon; V T K Chow; W C Tan; H P Van Bever
Journal:  Singapore Med J       Date:  2007-04       Impact factor: 1.858

6.  Increased risk of serious pneumococcal disease in patients with asthma.

Authors:  Young J Juhn; Hirohito Kita; Barbara P Yawn; Thomas G Boyce; Kwang H Yoo; Michaela E McGree; Amy L Weaver; Peter Wollan; Robert M Jacobson
Journal:  J Allergy Clin Immunol       Date:  2008-09-13       Impact factor: 10.793

7.  Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life.

Authors:  H Faden; L Duffy; A Williams; D A Krystofik; J Wolf
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

Review 8.  Innate immunity in the pathogenesis of virus-induced asthma exacerbations.

Authors:  Sebastian L Johnston
Journal:  Proc Am Thorac Soc       Date:  2007-07

9.  Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?

Authors:  Anne Kotaniemi-Syrjänen; Raija Vainionpää; Tiina M Reijonen; Matti Waris; Kaj Korhonen; Matti Korppi
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

10.  Human bocavirus and acute wheezing in children.

Authors:  Tobias Allander; Tuomas Jartti; Shawon Gupta; Hubert G M Niesters; Pasi Lehtinen; Riikka Osterback; Tytti Vuorinen; Matti Waris; Annelie Bjerkner; Annika Tiveljung-Lindell; Bernadette G van den Hoogen; Timo Hyypiä; Olli Ruuskanen
Journal:  Clin Infect Dis       Date:  2007-02-14       Impact factor: 9.079

View more
  10 in total

Review 1.  The relationships between environmental bacterial exposure, airway bacterial colonization, and asthma.

Authors:  Avraham Beigelman; George M Weinstock; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-04

Review 2.  Childhood Asthma Inception and Progression: Role of Microbial Exposures, Susceptibility to Viruses and Early Allergic Sensitization.

Authors:  Fernando D Martinez
Journal:  Immunol Allergy Clin North Am       Date:  2019-05       Impact factor: 3.479

3.  Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children.

Authors:  Alejandro Diaz-Diaz; Eleonora Bunsow; Cristina Garcia-Maurino; Melissa Moore-Clingenpeel; Jeffrey Naples; Alexis Juergensen; Sara Mertz; Huanyu Wang; Amy L Leber; James Gern; Mark W Hall; Daniel M Cohen; Octavio Ramilo; Asuncion Mejias
Journal:  J Infect Dis       Date:  2022-03-02       Impact factor: 7.759

Review 4.  Environmental determinants of allergy and asthma in early life.

Authors:  Allison J Burbank; Amika K Sood; Matthew J Kesic; David B Peden; Michelle L Hernandez
Journal:  J Allergy Clin Immunol       Date:  2017-07       Impact factor: 10.793

5.  Clinical characteristics of children with lower respiratory tract infections are dependent on the carriage of specific pathogens in the nasopharynx.

Authors:  T Tenenbaum; A Franz; N Neuhausen; R Willems; J Brade; S Schweitzer-Krantz; O Adams; H Schroten; B Henrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-01       Impact factor: 3.267

Review 6.  Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.

Authors:  V T Devine; J M Jefferies; S C Clarke; S N Faust
Journal:  J Immunol Res       Date:  2015-08-16       Impact factor: 4.818

7.  Overnutrition, Nasopharyngeal Pathogenic Bacteria and Proinflammatory Cytokines in Infants with Viral Lower Respiratory Tract Infections.

Authors:  Guisselle Arias-Bravo; Gustavo Valderrama; Jaime Inostroza; Cecilia Tapia; Daniela Toro-Ascuy; Octavio Ramilo; Paz Orellana; Nicolás Cifuentes-Muñoz; Francisco Zorondo-Rodríguez; Asunción Mejias; Loreto F Fuenzalida
Journal:  Int J Environ Res Public Health       Date:  2022-07-19       Impact factor: 4.614

8.  Tracheal colonization factor A (TcfA) is a biomarker for rapid and specific detection of Bordetella pertussis.

Authors:  Amanda R Burnham-Marusich; Ryan K Olsen; Jacqueline Scarbrough; Alexander Kvam; Wei Yang; Lindsey Zimmerman; James J Dunn; Tod Merkel; Thomas R Kozel
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

9.  Risk factors for adverse outcomes of Indigenous infants hospitalized with bronchiolitis.

Authors:  Gabrielle B McCallum; Mark D Chatfield; Peter S Morris; Anne B Chang
Journal:  Pediatr Pulmonol       Date:  2015-11-17

10.  Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial.

Authors:  Jakob Stokholm; Bo L Chawes; Nadja H Vissing; Elín Bjarnadóttir; Tine M Pedersen; Rebecca K Vinding; Ann-Marie M Schoos; Helene M Wolsk; Sunna Thorsteinsdóttir; Henrik W Hallas; Lambang Arianto; Susanne Schjørring; Karen A Krogfelt; Thea K Fischer; Christian B Pipper; Klaus Bønnelykke; Hans Bisgaard
Journal:  Lancet Respir Med       Date:  2015-12-17       Impact factor: 30.700

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.